title: Long-term antiretroviral efficacy and safety of lopinavir/ritonavir in HAART-experienced subjects: 4 year follow-up study.
authors.forename: Marco
authors.initials: M
authors.lastname: Bongiovanni
authors.forename: Teresa
authors.initials: T
authors.lastname: Bini
authors.forename: Amedeo
authors.initials: A
authors.lastname: Capetti
authors.forename: Serena
authors.initials: S
authors.lastname: Trovati
authors.forename: Antonio
authors.initials: A
authors.lastname: Di Biagio
authors.forename: Federica
authors.initials: F
authors.lastname: Tordato
authors.forename: Antonella d'Arminio
authors.initials: Ad
authors.lastname: Monforte
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D019438:Ritonavir / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D012367:RNA, Viral; D061466:Lopinavir; D019438:Ritonavir